Literature DB >> 7991115

In situ demonstration of the HTLV-I genome in the spinal cord of a patient with HTLV-I-associated myelopathy.

Y Kuroda1, M Matsui, M Kikuchi, K Kurohara, C Endo, M Yukitake, Y Matsuda, O Tokunaga, A Komine-Sakaki, R Kawaguchi.   

Abstract

Using polymerase chain reaction (PCR) and in situ hybridization, we investigated the HTLV-I genome in the CNS of an HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patient with a 20-year disease duration. Neuropathologically, there was severe white matter degeneration throughout the spinal cord, but lymphocytic infiltrates were not evident in any lesion. PCR amplification of the pX region of HTLV-I DNA detected its sequence in the spinal cord and all extra-CNS tissue samples. In situ hybridization using probes complementary to the pX and gag regions detected the HTLV-I genome in the cytoplasm and nucleus of cells in the thoracic cord. The findings indicate a direct involvement of HTLV-I in the neurodegeneration of HAM/TSP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7991115     DOI: 10.1212/wnl.44.12.2295

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T-cell lymphotropic virus type 1 Tax.

Authors:  E P Cowan; R K Alexander; S Daniel; F Kashanchi; J N Brady
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

2.  Analysis of the T-cell receptor repertoire of human T-cell leukemia virus type 1 (HTLV-1) Tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion.

Authors:  U Utz; D Banks; S Jacobson; W E Biddison
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

Review 3.  Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease.

Authors:  Veronique Lepoutre; Pooja Jain; Kevin Quann; Brian Wigdahl; Zafar K Khan
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.